Effect of Internal Brace on Outcomes Following ACL Reconstruction With BTB Autograft

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-35
SponsorNYU Langone Health

About this trial

The purpose of this study is to assess Anterior Cruciate Ligament (ACL) healing through analyzing clinical, radiographic, functional and patient-reported outcomes following ACL reconstruction with bone-tendon-bone autograft with and without internal bracing.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients undergoing ACLR with BTB autograft

Patients ages 18-35, inclusive

Ability to undergo standard rehab protocol and full, painless range of motion at the time of surgery of their operative knee

Disqualifiers

Osteoarthritis defined by Kellgren-Lawrence grade 2 or higher on preoperative weightbearing radiographs

Significant chondral injury as defined by grade 3-4 lesion greater than 2cm2

History of autoimmune or inflammatory disease

Prior ipsilateral knee ligament surgery or multi-ligament knee injury

Trial design

Design model

Parallel

Treatments tested in this trial

  • Arthrex Internal Brace

    Device

    The Arthrex Internal Brace method for ACL reconstruction consists of suture tape used to reinforce the ACL during surgery. This suture tape is secured in place with bioabsorbable anchors that gradually degrade within the body over time.

  • ACL Reconstruction

    Procedure/Surgery

    All patients will undergo ACL reconstruction (ACLR) with or without an internal brace. ACLR technique will be standardized to standard anteromedial (AM) portal femoral drilling to ensure consistency between surgeons.

Treatment groups

90 Participants
are divided into 2 treatment groups
Group A: Internal BraceExperimental treatment 2 interventions
Group B: Standard ACLRActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Side to side difference in laxity as measured by the KT-1000 Arthrometer

The KT-1000 knee arthrometer (KT-1000) is an objective instrument to measure anterior tibial motion relative to the femur for anterior cruciate ligament (ACL) reconstruction. The side-to-side differences comparing the injured and normal extremity allow the determination of a diagnosis of increased anterior-posterior laxity. A side-to-side difference of less than 3mm at 30lb and the manual maximum is considered normal. A side-to-side difference between 3 and 5mm is considered a grey area. A side-to-side difference of more than 5mm is considered diagnostic of an ACL tear.

Time frame
Month 12 Post-Operation
2

Side to side difference in laxity as measured by the KT-1000 Arthrometer

The KT-1000 knee arthrometer (KT-1000) is an objective instrument to measure anterior tibial motion relative to the femur for anterior cruciate ligament (ACL) reconstruction. The side-to-side differences comparing the injured and normal extremity allow the determination of a diagnosis of increased anterior-posterior laxity. A side-to-side difference of less than 3mm at 30lb and the manual maximum is considered normal. A side-to-side difference between 3 and 5mm is considered a grey area. A side-to-side difference of more than 5mm is considered diagnostic of an ACL tear.

Time frame
Month 24 Post-Operation

Secondary outcomes

1

Pivot Shift Grade

The Pivot Shift test is a dynamic, passive test to assess the rotational instability of the Anterior Cruciate Ligament in the knee. Pivot shift grades include: equal/0 (negative); glide/1; clunk/2; gross/3. A positive grade indicates injury to the Anterior Cruciate Ligament.

Time frame
Month 12 Post-Operation
2

Pivot Shift Grade

The Pivot Shift test is a dynamic, passive test to assess the rotational instability of the Anterior Cruciate Ligament in the knee. Pivot shift grades include: equal/0 (negative); glide/1; clunk/2; gross/3. A positive grade indicates injury to the Anterior Cruciate Ligament.

Time frame
Month 24 Post-Operation
3

Change from Baseline in Visual Analogue Scale (VAS) - Pain Score at Month 12 Post-Operation

Participants rate their pain on a scale from 0 (no pain) to 10 (worst pain imaginable); the response is the total score.

Time frame
Baseline, Month 12 Post-Operation
4

Change from Baseline in Visual Analogue Scale (VAS) - Pain Score at Month 24 Post-Operation

Participants rate their pain on a scale from 0 (no pain) to 10 (worst pain imaginable); the response is the total score.

Time frame
Baseline, Month 24 Post-Operation

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.